(25S)-5alpha-spirostan-3beta-ol-3-O-beta-D-galactopyranosyl- (1→2)-O-[beta-D-glucopyranosyl-(1→3)]-O-beta-Dglucopyranosyl-(1→4)-beta-D-galactopyranoside - Compound Card

(25S)-5alpha-spirostan-3beta-ol-3-O-beta-D-galactopyranosyl- (1→2)-O-[beta-D-glucopyranosyl-(1→3)]-O-beta-Dglucopyranosyl-(1→4)-beta-D-galactopyranoside

Select a section from the left sidebar

(25S)-5alpha-spirostan-3beta-ol-3-O-beta-D-galactopyranosyl- (1→2)-O-[beta-D-glucopyranosyl-(1→3)]-O-beta-Dglucopyranosyl-(1→4)-beta-D-galactopyranoside

Structure
Zoomed Structure
  • Family: Plantae - Zygophyllaceae
  • Kingdom: Plantae
  • Class: Steroid
    • Subclass: Steroidal Glycoside
Canonical Smiles OCC1O[C@@H](OC2CC[C@]3([C@H](C2)CCC2C3CC[C@]3(C2CC2C3[C@H](C)C3(O2)CC[C@@H](CO3)C)C)C)C([C@H]([C@H]1O[C@@H]1OC(CO)[C@H]([C@@H](C1OC1OC(CO)C([C@H]([C@@H]1O)O)O)O[C@@H]1OC[C@H]([C@@H](C1O)O)O)O)O)O
InChI InChI=1S/C50H82O22/c1-20-7-12-50(64-18-20)21(2)32-28(72-50)14-26-24-6-5-22-13-23(8-10-48(22,3)25(24)9-11-49(26,32)4)65-45-40(62)37(59)41(31(17-53)68-45)69-47-43(71-46-39(61)36(58)34(56)29(15-51)66-46)42(35(57)30(16-52)67-47)70-44-38(60)33(55)27(54)19-63-44/h20-47,51-62H,5-19H2,1-4H3/t20-,21-,22-,23?,24?,25?,26?,27+,28?,29?,30?,31?,32?,33-,34?,35+,36+,37+,38?,39-,40?,41-,42-,43?,44-,45+,46?,47-,48-,49-,50?/m0/s1
InChIKey BJNQXJIQCPPOHN-YVSYBRMZSA-N
Formula C50H82O22
HBA 22
HBD 12
MW 1035.18
Rotatable Bonds 11
TPSA 335.06
LogP -2.27
Number Rings 10
Number Aromatic Rings 0
Heavy Atom Count 72
Formal Charge 0
Fraction CSP3 1.0
Exact Mass 1034.53
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Tribulus alatus Zygophyllaceae Plantae 2603137

Showing of synonyms

  • Temraz A, El Gindi OD, et al. (2006). Steroidal saponins from the aerial parts of Tribulus alatus Del.. Phytochemistry,2006,67(10),1011-1018. [View] [PubMed]
Pubchem: 163090096

No compound-protein relationship available.

Structure

SMILES: O1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(CC5)CC(CC6)OC(OC7)CCC7OC8OCCC(OC9CCCCO9)C8OC1CCCCO1

Level: 4

Mol. Weight: 1035.18 g/mol

Structure

SMILES: O1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(CC5)CC(CC6)OC(OC7)CCC7OC(OCCC8)C8OC9CCCCO9

Level: 3

Mol. Weight: 1035.18 g/mol

Structure

SMILES: O1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(CC5)CC(CC6)OC(OC7)CCC7OC(OCC8)CC8OC9CCCCO9

Level: 3

Mol. Weight: 1035.18 g/mol

Structure

SMILES: O1CCCCC1OC2C(OC3CCCCO3)CCOC2OC4CCCOC4

Level: 3

Mol. Weight: 1035.18 g/mol

Structure

SMILES: O1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(CC5)CC(CC6)OC(OC7)CCC7OC8CCCCO8

Level: 2

Mol. Weight: 1035.18 g/mol

Structure

SMILES: O1CCCCC1OC2CC(OCC2)OC3CCCOC3

Level: 2

Mol. Weight: 1035.18 g/mol

Structure

SMILES: O1CCCCC1OC2C(OCCC2)OC3CCCOC3

Level: 2

Mol. Weight: 1035.18 g/mol

Structure

SMILES: O1CCCCC1OC2C(COCC2)OC3CCCCO3

Level: 2

Mol. Weight: 1035.18 g/mol

Structure

SMILES: O1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(CC5)CC(CC6)OC7CCCCO7

Level: 1

Mol. Weight: 1035.18 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1035.18 g/mol

Structure

SMILES: C1COCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1035.18 g/mol

Structure

SMILES: O1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(CC5)CCCC6

Level: 0

Mol. Weight: 1035.18 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1035.18 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.62
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
174677.72
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
22829242.57

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.73
Plasma Protein Binding
41.75
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
0.51
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-530947.81
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.99
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Toxic
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-41433965748.28
Rat (Acute)
3.79
Rat (Chronic Oral)
88.22
Fathead Minnow
52301556.67
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
4660169043.21
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-2581.51
Log(P)
0.44
Log S
-2.16
Log(Vapor Pressure)
-153456793.18
Melting Point
175.24
pKa Acid
-1118088.14
pKa Basic
-8978.39

No predicted protein targets found for this compound.

Download SDF